The largest database of trusted experimental protocols
> Procedures > Health Care Activity > Surgical Intensive Care

Surgical Intensive Care

Surgical Intensive Care refers to the specialized medical care provided to patients undergoing complex surgical procedures or recovering from major operations.
This field encompasses the monitoring, management, and treatment of critically ill surgical patients, often in dedicated intensive care units (ICUs).
Surgical Intensive Care focuses on maintaining vital organ function, preventing and managing complications, and optimizing the patient's recovery.
It involves the coordinated efforts of surgeons, anesthesiologists, critical care physicians, nurses, and other healthcare professionals to ensure the best possible outcomes for patients in this delicate and high-risk setting.
The goal of Surgical Intensive Care is to provide comprehensive, evidence-based care that addresses the unique needs of surgical patients and supports their safe transition back to the general ward or home.

Most cited protocols related to «Surgical Intensive Care»

acutely injured patients admitted to the Rocky Mountain Regional Trauma Center surgical intensive care unit (SICU) at Denver Health Medical Center (DHMC) were studied prospectively from 1992 through 2004. DHMC is a state designated Level I trauma center verified by the American College of Surgeons Committee on Trauma. Inclusion criteria were Injury Severity Score (ISS) greater than 15, survival longer than 48 hours from injury, admission to the SICU within 24 hours of injury, and age greater than 15 years. Patients with isolated head injuries [head injuries with an extra-cranial abbreviated injury score (AIS) less than two] were excluded. Burn patients and hanging injuries were not included.
Patient characteristics were recorded at the time of hospital admission. Daily physiologic and laboratory data were collected through SICU day 28 and clinical events were recorded on all patients thereafter until death or hospital discharge. The data collection and storage processes are in compliance with HIPAA regulations and have been approved by our Institutional Review Board.
Publication 2009
Craniocerebral Trauma Cranium Ethics Committees, Research Injuries Patient Discharge Patient Isolation Patients physiology Surgeons Surgical Intensive Care Wounds and Injuries
extracted from the MIMIC-II resource [37] (link), this comprises PPG recordings
and respiratory signals acquired using conventional impedance pneumography (IP), both sampled at Hz, from 53 adult patients (median age:
64.81, range: 19-90+, 32 females). Those in the dataset were selected from a larger cohort of patients who were
admitted to medical and surgical intensive care units at the Beth Israel Deaconess Medical Center (BIDMC), Boston,
USA. 53 recordings of 8-minute duration were randomly selected as the test set for this database.
The IP waveform for each record was used as the reference recording for RR. Each breath in the IP signals was
manually (independently) annotated by two research assistants, and both sets of annotations were used to derive the
reference RR values. For each set of annotations, the RR value was determined based on the average time between
consecutive breaths within a given window; only those windows of data for which the agreement between both estimates
was within 2 breaths per min were retained, and the mean value of the two estimates was taken as the reference RR. As
a result, using a window size of 32 s, for example, resulted in 97.5% of all available reference windows being
deemed to be “valid” according to our criterion.
Publication 2016
Adult Females Patients Respiratory Rate Surgical Intensive Care

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2020
Adult Bilirubin BLOOD Cholecalciferol Creatinine Critical Illness Diagnosis Discrimination, Psychology Drug Kinetics Freezing High-Performance Liquid Chromatographies Homo sapiens Patients Placebos Plant Roots Plasma Rain Student Surgical Intensive Care Tandem Mass Spectrometry Woman
The observational clinical study was approved by the local ethics committee (Ethics Committee of the Medical Faculty of Heidelberg, Trial Code No. S-097/2013/German Clinical Trials Register: DRKS00005463) and was conducted in the surgical intensive care unit of Heidelberg University Hospital, Germany, between November 2013 and January 2015. All study patients or their legal designees gave written informed consent. In total 50 patients suffering from septic shock according to the criteria of the Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock 2012 were enrolled in this study [106 (link)]. Treatment of patients with septic shock included early-goal directed therapy [107 (link)], elimination of the septic focus and broad-spectrum antibiosis [3 (link),107 (link),108 (link)]. Blood samples were collected at sepsis onset (T0) and 1 day (T1), 2 days (T2), 7 days (T3) 14 days (T4), 21 days (T5), and 28 days (T6) thereafter. Relevant baseline data (demographic data, primary site of infection), clinical data (disease severity scores, such as Simplified Acute Physiology Score (SAPS II), Sequential Organ Failure Assessment Score (SOFA) and Acute Physiology Health Evaluation score (APACHE II), surgical procedures, antifungal therapy, outcome parameters) as well as routine infection parameters (e.g. leukocytes, C-reactive protein (CRP), procalcitonin (PCT), body temperature) were collected.
Full text: Click here
Publication 2017
Antibiosis Antifungal Agents BLOOD Body Temperature C Reactive Protein Early Goal-Directed Therapy Ethics Committees Faculty, Medical Infection Leukocytes Operative Surgical Procedures Patients physiology Procalcitonin Regional Ethics Committees Septicemia Septic Shock Severe Sepsis Surgical Intensive Care Therapeutics
This study was conducted in three surgical intensive care units in National Taiwan University Hospital. Patients with medical uncertainty or conflict regarding value-laden issues, and requests made by the attending physicians or nurses for HCEC from December 1, 2009 to April 30, 2012 were randomly assigned, to the usual care group (UC group) and the intervention group (HCEC group). The patients in the UC group did not receive HCEC, but still received usual care such as family meeting, consultation to social workers and so on, which were considered appropriate by the health care team. The patients in the HCEC group received HCEC conducted by an individual ethics consultant. If a case was assigned to the HCEC group but the attending physician did not want to receive HCEC, the preference of not receiving HCEC was honored. If a case was assigned to the UC group but the attending physician wanted to receive HCEC, the preference of receiving HCEC was honored.
HCEC can be conducted by a hospital ethics committee, a small group of ethics consultants, or an individual ethics consultant [1 ]. In our study, we conducted HCEC by individual ethics consultants. The qualifications, skills and knowledge of an individual ethics consultant have been proposed by Aulisio et al. [20 (link)]. Our individual ethics consultants all have doctoral degrees, received more than a decade of training in clinical medicine, and completed more than 20 hours of clinical ethics educational courses per year. All ethics consultants, while conducting HCEC, were strongly encouraged to follow the suggestions proposed by Aulisio et al. [20 (link)]:
1) Gather relevant data.
2) Clarify relevant concepts.
3) Clarify related normative issues.
4) Help to identify a range of morally acceptable options within the context.
5) Facilitate consensus among involved parties.
Full text: Click here
Publication 2014
3-hydroxycholest-7-ene-14-carbaldehyde Ethicists Ethics Committees, Clinical Medical Care Team Nurses Patients Physicians Surgical Intensive Care

Most recents protocols related to «Surgical Intensive Care»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Adult COVID 19 Health Personnel Operative Surgical Procedures Patients Surgical Intensive Care

Human data from secondary analyses of patients participating in the VISS-trial (German Clinical Trials Register: DRKS00000505). The VISS-trial was first approved by the local ethics committee (Trial-Code-Nr.: S058-2009) on June, 8th 2009, and was conducted in the surgical intensive care unit of the University Hospital of Heidelberg, Germany. In total, 60 patients within the VISS-cohort, classified according to the criteria of the International Sepsis Definitions Conference, were enrolled with an onset of sepsis syndrome ≤ 24 hours. 1 patient from the published VISS-trial was excluded from the retrospective analysis because it was a significant outlier for plasma IL-3 levels. Written informed consents were obtained from the study patients or their legal designees. Patients were eligible for enrollment with an onset of sepsis syndrome within 24 h. The initial blood draw was also performed within this period. In contrast, patients with an onset of sepsis syndrome > 24 h were excluded from the study. The management of patients with septic shock in the intensive care unit included early goal-directed therapy (according to Rivers and colleagues), elimination of the septic focus, and broad-spectrum antibiotics. Patients with preexisting immunosuppressive diseases were excluded from the study. Blood samples (EDTA) as well as deep tracheal secretion samples from patients with septic shock were collected after the diagnosis of sepsis at sepsis onset (day 0), as well as 1, 7, 14, 21, and 28 days (VISS-trial) later. Afterwards, the virologic diagnostics were performed as previously described (61 (link)) and correlated to the clinical outcome. For the presented IL-3 measurements an amendment was submitted to the local ethics committee which was approved on November, 22th 2013. Human data from prospective measurements and analyses of patients participating in the SEPICER-trial. The SEPICER-trial was first approved by the local ethics committee on February 1, 2021 (UKER 459_20B), and was conducted in the surgical intensive care unit of the University Hospital of Erlangen, Germany. In total, 32 septic patients and 30 patients positive for SARS-CoV-2 PCR from oral swabs, oral fluid, or BALF were enrolled in this trial. Patients with low IL-3 are patients with a level of IL-3 under the mean (61.7 pg/ml) of all the patients. Patients with high IL-3 are patients with a level of IL-3 above the mean (61.7 pg/ml) of all the patients.
Full text: Click here
Publication 2023
Antibiotics BLOOD Conferences Diagnosis Early Goal-Directed Therapy Edetic Acid Homo sapiens Immunosuppressive Agents Patients Plasma Regional Ethics Committees Rivers SARS-CoV-2 secretion Septicemia Septic Shock Surgical Intensive Care Systemic Inflammatory Response Syndrome Trachea
Patient subjects were drawn from the population of the Surgical Intensive Care Unit at Beth Israel and the Mount Sinai Kravis Children’s Hospital, both located in Manhattan, New York, US. Patient criteria included the following groups: Pediatric ICU, Cancer, Spine, General Surgery and Gynecology, and were adjusted for the severity of illness with a widely used severity index (APACHE II.) Referrals from doctors, nurses, and social workers of patients who were defined as high acuity (see Appendix A), and who met the inclusion criteria were enrolled. Staff subjects included: ICU Attending Doctors, Surgery Residents, Consultant Attending Doctors, Nurses, and Physician Assistants. Subjects included patients, their family members and/or caregivers, and their staff nurses, doctors and therapists who met the study criteria as identified from the PICU and SICU teams. Caregiver/family member subjects were identified by patients and their medical staff. All subjects were considered regardless of gender or racial/ethnic background except for any subjects that declined to participate in the study.
Full text: Click here
Publication 2023
Consultant Ethnicity Family Member Gender Malignant Neoplasms Medical Staff Nurses Operative Surgical Procedures Patients Physician Assistant Physicians Surgical Intensive Care Vertebral Column
This was a secondary retrospective analysis of two prospective studies. The first, an observational clinical study, approved by the Ethics Committee of the Medical Faculty of Heidelberg (Trial-Code No. S-196/2014), was performed in the emergency room and surgical intensive care unit of the University Hospital of Heidelberg, Germany, between July 2014 and March 2015 [17 (link)].
The second, an observational cohort study, approved by the Ethics Committee of the Medical Faculty of Heidelberg (Trial-Code No. S-196/2014 and No. S-391/2015) and the Rhineland-Pfalz Medical Board (file number: 837.539.15/10307), was performed in the emergency room and intensive care unit of the BG Trauma Centre Ludwigshafen/Rhine, Germany, between April 2016 and December 2016 [19 (link)].
In both studies, informed consent was obtained from patients or their legal designees and all volunteers. The methods conformed to the relevant regulations and guidelines.
Full text: Click here
Publication 2023
Ethics Committees Faculty, Medical Patients Surgical Intensive Care Voluntary Workers Wounds and Injuries
The thrombolysis procedures were performed by interventional radiologists. Under local anaesthesia, the right femoral artery was punctured in accordance with the Seldinger technique, and a 10 cm long 6 Fr sheath (Terumo, Tokyo, Japan) was implanted. Selective catheterisation of the SMA was performed using an 80 cm long 4 Fr catheter (J curve; Terumo). SMA angiography was performed to identify the filling defects. Thrombolysis was performed using a 5 Fr multiple-sideport infusion catheter (100 cm with fourteen 7 cm sideports or 100 cm with thirty 15 cm sideports; Cook, Bloomington, IN, USA). The tip of the microcatheter was embedded in the thromboembolism, and our infusion protocol was started with intrathrombus pulse-spray injection of urokinase (urokinase-GCC injection, 250,000 IU) with a loading dose of 300,000 IU in 20 mL of normal saline in the first 3 patients and 250,000 IU in the next 10 patients, followed by a maintenance dose of 50,000 IU/h for 3 days. Intravenous heparin was administered simultaneously under close monitoring and surveillance in the surgical intensive care unit. Possible hemorrhagic complications, such as intracranial haemorrhage, gastrointestinal bleeding, or puncture site oozing, were assessed, and the fibrinogen levels were checked every 6 h and the dose of urokinase was adjusted or discontinued for fibrinogen < 200 mg/dL. Follow-up angiography was usually performed once daily for 3 days or discontinued when clinical deterioration occurred. The patient was discharged with a warfarin prescription. Data on age, sex, clinical presentation, imaging studies such as abdominal CT and angiography, SMA occlusion location and degree, time and response to urokinase treatment, and clinical outcomes were retrospectively evaluated.
Full text: Click here
Publication 2023
Abdomen Angiography Catheterization Catheters Clinical Deterioration Dental Occlusion Femoral Artery Fibrinogen Fibrinolytic Agents Hemorrhage Heparin Intracranial Hemorrhage Local Anesthesia Normal Saline Patients Pulse Rate Punctures Radiologist Surgical Intensive Care Thromboembolism Urokinase Warfarin

Top products related to «Surgical Intensive Care»

Sourced in France, United States
The Vitek GNI card is a lab equipment product designed for bacterial identification. It provides a rapid and automated method for the identification of Gram-negative bacteria. The Vitek GNI card contains a series of biochemical tests that analyze the metabolic profile of the bacterial sample, allowing for accurate identification.
Sourced in United States, Denmark, Austria, United Kingdom, Japan, Canada
Stata version 14 is a software package for data analysis, statistical modeling, and graphics. It provides a comprehensive set of tools for data management, analysis, and reporting. Stata version 14 includes a wide range of statistical techniques, including linear regression, logistic regression, time series analysis, and more. The software is designed to be user-friendly and offers a variety of data visualization options.
Sourced in Italy, United States, Denmark, United Kingdom
The ESwab is a specimen collection and transport system designed for the collection, transport, and preservation of clinical specimens. It consists of a flocked swab and a tube containing a modified liquid Amies medium. The ESwab is intended to maintain the viability of aerobic, anaerobic, and fastidious microorganisms during transport to the laboratory for analysis.
Sourced in United States
SPSS v.21 for Windows is a statistical software package designed to analyze data and manage information. It provides a comprehensive set of tools for data management, analysis, and visualization. SPSS v.21 is compatible with the Windows operating system.
Sourced in Sweden
The Servo Ventilator 300 is a medical device designed to provide mechanical ventilation support. It is capable of assisting patients with their breathing by delivering controlled volumes of air or oxygen-enriched air. The device is designed to operate with a range of ventilation modes and settings to accommodate varying patient needs.
Sourced in Germany, United States, United Kingdom, France, Finland
The Microflex LT is a compact, lightweight MALDI-TOF mass spectrometer designed for routine protein and peptide analysis. It provides reliable performance and ease of use for a wide range of applications in life science research and clinical diagnostics.
Sourced in Germany, United States, United Kingdom, Australia, Ireland
The ADVIA 2120 is a fully automated hematology analyzer designed for clinical laboratory use. It is capable of performing complete blood count (CBC) and white blood cell differential analysis on a variety of sample types. The ADVIA 2120 utilizes flow cytometry and laser-based technology to provide accurate and reliable results.
Sourced in United States, Japan, United Kingdom, Germany, Israel, Thailand
SPSS version 17.0 is a statistical software package developed by IBM. It provides a comprehensive set of tools for data analysis, including data manipulation, visualization, and predictive modeling. The software is designed to handle a wide range of data types and offers a user-friendly interface for conducting complex statistical analyses.
Sourced in France, United States
IntelliSpace Critical Care and Anesthesia is a comprehensive patient monitoring and clinical information management solution designed for critical care and anesthesia environments. The system integrates real-time patient data, clinical decision support, and workflow tools to help clinicians make informed decisions and improve patient care.
Sourced in United States
The ADVIA XPT system is a laboratory testing platform designed for high-throughput clinical chemistry and immunoassay analysis. It provides automated processing and analysis of a wide range of clinical samples.

More about "Surgical Intensive Care"

Surgical Intensive Care, also known as Critical Care Surgery or Surgical Critical Care, refers to the specialized medical care provided to patients undergoing complex surgical procedures or recovering from major operations.
This field encompasses the monitoring, management, and treatment of critically ill surgical patients, often in dedicated Intensive Care Units (ICUs).
Surgical Intensive Care focuses on maintaining vital organ function, preventing and managing complications, and optimizing the patient's recovery.
It involves the coordinated efforts of surgeons, anesthesiologists, critical care physicians, nurses, and other healthcare professionals to ensure the best possible outcomes for patients in this delicate and high-risk setting.
The goal of Surgical Intensive Care is to provide comprehensive, evidence-based care that addresses the unique needs of surgical patients and supports their safe transition back to the general ward or home.
This specialized field of medicine utilizes a variety of advanced medical technologies and tools to monitor and treat critically ill surgical patients.
Some of the equipment and systems commonly used in Surgical Intensive Care include the Servo Ventilator 300 for mechanical ventilation, the ADVIA 2120 hematology analyzer for blood analysis, the IntelliSpace Critical Care and Anesthesia platform for integrated patient monitoring and data management, and the ADVIA XPT system for rapid diagnostic testing.
Additionally, the Microflex LT gloves and ESwab sample collection system may be employed to maintain sterile conditions and facilitate accurate specimen collection.
Surgical Intensive Care practitioners often collaborate with other medical specialists, such as using the Vitek GNI card for microbial identification and the SPSS version 17.0 and Stata version 14 statistical software for data analysis to optimize patient outcomes.
By leveraging these advanced tools and technologies, Surgical Intensive Care teams are able to provide the highest level of care to their critically ill surgical patients, supporting their safe recovery and transition back to the general ward or home.